stockrowJourney Medical Corporation (DERM) vs Organogenesis (ORGO)
- Journey Medical Corporation DERM 4.42 +2.79%
- Organogenesis ORGO 0.89 +5.95%
Journey Medical Corporation and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Journey Medical Corporation is the larger, with a market value of $121.4M against $108.1M — 1.1× the size. Journey Medical Corporation grew revenue faster over the last twelve months: 20.9% against −24.3%. Journey Medical Corporation has the higher net margin (−8.95% vs −43.5%) and the higher return on invested capital (−5.89% vs −52.2%). Across the 19 metrics below, Organogenesis leads on 12 and Journey Medical Corporation on 7.
Valuation
Profitability
| Metric | DERM | ORGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.45% | 65.56% | 53.51% |
| Operating margin | (4.41%) | (24.45%) | 0.00% |
| Net margin | (8.95%) | (43.50%) | (2.45%) |
| Free cash flow margin | (10.99%) | 1.01% | 0.00% |
| Return on equity | (23.77%) | (81.71%) | (0.80%) |
| Return on assets | (6.80%) | (34.86%) | (1.67%) |
| Return on invested capital | (5.89%) | (52.15%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack